This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Crescendo Biologics Limited. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Lorraine Thompson: Innovator in Therapeutic Molecules
Introduction
Lorraine Thompson is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic molecules. With a total of three patents to her name, Lorraine is recognized for her innovative approaches to cancer treatment.
Latest Patents
Among her latest patents, Lorraine has focused on binding molecules that specifically target prostate-specific membrane antigen (PSMA). Her inventions include single human variable heavy chain domain antibodies and related methods for the treatment of cancer. These advancements hold promise for improving therapeutic options for patients.
Career Highlights
Lorraine currently works at Crescendo Biologics Limited, where she continues to push the boundaries of scientific research and innovation. Her work is characterized by a commitment to developing effective treatments that can make a difference in the lives of patients battling cancer.
Collaborations
Lorraine collaborates with notable colleagues, including Brian Timothy McGuinness and Chris Rossant. These partnerships enhance her research efforts and contribute to the advancement of therapeutic solutions.
Conclusion
Lorraine Thompson's contributions to the field of therapeutic molecules exemplify her dedication to innovation in cancer treatment. Her work not only showcases her expertise but also highlights the potential for new therapies that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile